- Report
- January 2026
- 185 Pages
Global
From €3185EUR$3,545USD£2,778GBP
€3539EUR$3,939USD£3,086GBP
From €4402EUR$4,900USD£3,839GBP
- Report
- April 2026
- 179 Pages
Global
From €5256EUR$5,850USD£4,584GBP
- Report
- April 2026
- 299 Pages
Global
From €5256EUR$5,850USD£4,584GBP
- Report
- January 2026
- 180 Pages
Global
From €4043EUR$4,500USD£3,526GBP
- Report
- June 2025
- 150 Pages
Global
From €2425EUR$2,699USD£2,115GBP
- Report
- June 2025
- 150 Pages
Global
From €2425EUR$2,699USD£2,115GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,518GBP
- Report
- November 2025
- 200 Pages
Global
From €7143EUR$7,950USD£6,229GBP
- Report
- June 2025
- 200 Pages
Global
From €2506EUR$2,789USD£2,185GBP
- Report
- September 2025
- 150 Pages
Global
From €5346EUR$5,950USD£4,662GBP
- Report
- August 2025
- 188 Pages
Global
From €3185EUR$3,545USD£2,778GBP
€3539EUR$3,939USD£3,086GBP
- Report
- April 2026
- 486 Pages
Global
From €5256EUR$5,850USD£4,584GBP
- Report
- April 2026
- 285 Pages
Global
From €5256EUR$5,850USD£4,584GBP
- Report
- May 2025
- 150 Pages
Global
From €4358EUR$4,850USD£3,800GBP
- Report
- December 2025
- 139 Pages
Global
From €4358EUR$4,850USD£3,800GBP
- Report
- June 2025
- 150 Pages
United States
From €5346EUR$5,950USD£4,662GBP
- Report
- March 2024
- 200 Pages
Global
From €3729EUR$4,150USD£3,252GBP
- Report
- January 2024
- 200 Pages
Global
From €3729EUR$4,150USD£3,252GBP
- Report
- December 2024
- 165 Pages
Global
From €3549EUR$3,950USD£3,095GBP

The Heart Failure Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat a variety of heart-related conditions. Heart Failure Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs can help reduce symptoms, improve quality of life, and reduce the risk of death. Commonly used Heart Failure Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. These drugs work by reducing the workload on the heart, improving blood flow, and reducing fluid buildup in the body.
Some companies in the Heart Failure Drug market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more